n. any of a class of
vasoconstrictor drugs used in the treatment of migraine headache, the prototype of which is
sumatriptan. Triptans exert their therapeutic effect by acting as
serotonin agonists at 5-HT
1B and 5-HT
1D receptors, causing the constriction of cerebral blood vessels. Triptans should not be administered concurrently with
monoamine oxidase inhibitors and should be used cautiously with
SSRIs to avoid the risk of precipitating a
serotonin syndrome.